Micro-RNA-34a contributes to the impaired function of bone marrow-derived mononuclear cells from patients with cardiovascular disease.
暂无分享,去创建一个
A. Zeiher | S. Dimmeler | F. Seeger | B. Assmus | Yi‐Gang Li | R. Boon | K. Iekushi | Quanfu Xu | J. Castillo | Yosif Manavski | R. Farcas
[1] Ha Won Kim,et al. microRNA-150 Regulates Mobilization and Migration of Bone Marrow-Derived Mononuclear Cells by Targeting Cxcr4 , 2011, PloS one.
[2] J. Zavadil,et al. miR-30b/30d regulation of GalNAc transferases enhances invasion and immunosuppression during metastasis. , 2011, Cancer cell.
[3] D. Fliser,et al. Circulating miR-210 predicts survival in critically ill patients with acute kidney injury. , 2011, Clinical journal of the American Society of Nephrology : CJASN.
[4] Zhaoli Chen,et al. DNA hypermethylation of microRNA-34b/c has prognostic value for stage Ⅰ non-small cell lung cancer , 2011, Cancer biology & therapy.
[5] S. Dimmeler,et al. Kruppel-like factor 2 improves neovascularization capacity of aged proangiogenic cells. , 2011, European heart journal.
[6] E. Olson,et al. Pervasive roles of microRNAs in cardiovascular biology , 2011, Nature.
[7] B. Verdoodt,et al. Frequent concomitant inactivation of miR-34a and miR-34b/c by CpG methylation in colorectal, pancreatic, mammary, ovarian, urothelial, and renal cell carcinomas and soft tissue sarcomas , 2011, Virchows Archiv.
[8] M. Yamakuchi,et al. MicroRNA-34a regulation of endothelial senescence. , 2010, Biochemical and biophysical research communications.
[9] Qingbo Xu,et al. Short Communication: Asymmetric Dimethylarginine Impairs Angiogenic Progenitor Cell Function in Patients With Coronary Artery Disease Through a MicroRNA-21–Dependent Mechanism , 2010, Circulation research.
[10] D. Srivastava,et al. MicroRNAs as regulators of differentiation and cell fate decisions. , 2010, Cell stem cell.
[11] A. Kazlauskas. Faculty Opinions recommendation of An epigenetic switch involving NF-kappaB, Lin28, Let-7 MicroRNA, and IL6 links inflammation to cell transformation. , 2010 .
[12] A. Zeiher,et al. Mechanism of Improved Cardiac Function After Bone Marrow Mononuclear Cell Therapy: Role of Cardiovascular Lineage Commitment , 2010, Circulation.
[13] A. Avogaro,et al. Time Course and Mechanisms of Circulating Progenitor Cell Reduction in the Natural History of Type 2 Diabetes , 2010, Diabetes Care.
[14] H. Hermeking. The miR-34 family in cancer and apoptosis , 2010, Cell Death and Differentiation.
[15] Y. Pilpel,et al. p53-independent upregulation of miR-34a during oncogene-induced senescence represses MYC , 2010, Cell Death and Differentiation.
[16] Robert L. Judson,et al. Opposing microRNA families regulate self-renewal in mouse embryonic stem cells , 2010, Nature.
[17] Joshua M Hare,et al. A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction. , 2009, Journal of the American College of Cardiology.
[18] Kevin Struhl,et al. An Epigenetic Switch Involving NF-κB, Lin28, Let-7 MicroRNA, and IL6 Links Inflammation to Cell Transformation , 2009, Cell.
[19] J. Loscalzo,et al. MicroRNA-210 controls mitochondrial metabolism during hypoxia by repressing the iron-sulfur cluster assembly proteins ISCU1/2. , 2009, Cell metabolism.
[20] Stefanie Dimmeler,et al. MicroRNA-92a Controls Angiogenesis and Functional Recovery of Ischemic Tissues in Mice , 2009, Science.
[21] A. Zernecke,et al. Caffeine Enhances Endothelial Repair by an AMPK-Dependent Mechanism , 2008, Arteriosclerosis, thrombosis, and vascular biology.
[22] Sean J. Morrison,et al. Hmga2 Promotes Neural Stem Cell Self-Renewal in Young but Not Old Mice by Reducing p16Ink4a and p19Arf Expression , 2008, Cell.
[23] S. Dimmeler,et al. Role of paracrine factors in stem and progenitor cell mediated cardiac repair and tissue fibrosis , 2008, Fibrogenesis & tissue repair.
[24] M. Yamakuchi,et al. miR-34a repression of SIRT1 regulates apoptosis , 2008, Proceedings of the National Academy of Sciences.
[25] Carola Berking,et al. Inactivation of miR-34a by aberrant CpG methylation in multiple types of cancer , 2008, Cell cycle.
[26] S. Dimmeler,et al. Aging and disease as modifiers of efficacy of cell therapy. , 2008, Circulation research.
[27] S. Kauppinen,et al. LNA-mediated microRNA silencing in non-human primates , 2008, Nature.
[28] G. Biondi-Zoccai,et al. Impact of intracoronary cell therapy on left ventricular function in the setting of acute myocardial infarction: a collaborative systematic review and meta-analysis of controlled clinical trials. , 2007, Journal of the American College of Cardiology.
[29] Stefanie Dimmeler,et al. Cell-Based Therapy of Myocardial Infarction , 2007, Arteriosclerosis, thrombosis, and vascular biology.
[30] V. Tarasov,et al. Differential Regulation of microRNAs by p53 Revealed by Massively Parallel Sequencing: miR-34a is a p53 Target That Induces Apoptosis and G1-arrest , 2007, Cell cycle.
[31] L. Lim,et al. A microRNA component of the p53 tumour suppressor network , 2007, Nature.
[32] K. Poh,et al. Intramyocardial Transplantation of Autologous CD34+ Stem Cells for Intractable Angina: A Phase I/IIa Double-Blind, Randomized Controlled Trial , 2007, Circulation.
[33] C. Heeschen,et al. Selective functional exhaustion of hematopoietic progenitor cells in the bone marrow of patients with postinfarction heart failure. , 2007, Journal of the American College of Cardiology.
[34] Michael A. Beer,et al. Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis. , 2007, Molecular cell.
[35] Moshe Oren,et al. Transcriptional activation of miR-34a contributes to p53-mediated apoptosis. , 2007, Molecular cell.
[36] P. Galuppo,et al. Endothelial Nitric Oxide Synthase Uncoupling Impairs Endothelial Progenitor Cell Mobilization and Function in Diabetes , 2007, Diabetes.
[37] E. Foster,et al. Validation of the wall motion score and myocardial performance indexes as novel techniques to assess cardiac function in mice after myocardial infarction. , 2007, American journal of physiology. Heart and circulatory physiology.
[38] A. Zeiher,et al. Transcoronary transplantation of progenitor cells after myocardial infarction. , 2006, The New England journal of medicine.
[39] A. Zeiher,et al. p38 Mitogen-Activated Protein Kinase Downregulates Endothelial Progenitor Cells , 2005, Circulation.
[40] Bernd Hertenstein,et al. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial , 2004, The Lancet.
[41] A. Zeiher,et al. Transplantation of Progenitor Cells and Regeneration Enhancement in Acute Myocardial Infarction (TOPCARE-AMI) , 2002, Clinical research in cardiology : official journal of the German Cardiac Society.
[42] Xiaofei Li,et al. TRANSFORMATION , 2001, Human Rights: Universality and Diversity.
[43] S. Dimmeler,et al. Control of cardiovascular differentiation by microRNAs , 2010, Basic Research in Cardiology.
[44] Robert L. Judson,et al. Opposing microRNA families regulate self-renewal in mouse embryonic stem cells , 2010, Nature.
[45] A. Zeiher,et al. p 38 Mitogen-Activated Protein Kinase Downregulates Endothelial Progenitor Cells , 2005 .
[46] Zhaohui S. Qin,et al. Supplemental Data S 1 p 53-Mediated Activation of miRNA 34 Candidate Tumor-Suppressor Genes , 2022 .